FDA sanctions clearance for Medrobotic’s Transabdominal and Transthoracic Robotic Scope

Medrobotics Corporation asserted that FDA has granted clearance to promulgate the Flex Robotics System for robot-assisted visualization in general surgical, gynecological and thoracic procedures in the United States thereby confirming the Company’s progress to develop trans formative products for single-port general gynecological, thoracic and urological surgeries. Medrobotics provides Scarfree access to hard- to reach anatomy in otolaryngology and colorectal procedures.

CEO Samuel Straface, Ph.D said “This clearance is a vital step in our commitment to minimize the impact of surgery by offering less invasive procedures through a single incision in the abdomen or thoracic cavity versus the multiple incisions that are currently required.”